Copyright
©The Author(s) 2015.
World J Gastroenterol. May 28, 2015; 21(20): 6304-6309
Published online May 28, 2015. doi: 10.3748/wjg.v21.i20.6304
Published online May 28, 2015. doi: 10.3748/wjg.v21.i20.6304
Table 1 Baseline characteristics of patients in the two groups
Characteristic | Study group(n = 15) | Control group(n = 16) | P value |
Age (yr) | 42.6 ± 9.9 | 40.9 ± 12.6 | 0.6806 |
BMI (kg/m2) | 27.4 ± 4.1 | 28.5 ± 3.7 | 0.4387 |
Sex (male/female), n | 10/5 | 11/5 | 1.0000 |
Bacterial culture positive, n | 3 | 4 | 1.0000 |
Marshall score | 2.6 ± 1.7 | 2.5 ± 1.4 | 0.8590 |
APACHE II score | 21.3 ± 2.9 | 22.5 ± 2.1 | 0.1952 |
Upper gastrointestinal bleeding, n | 7 | 8 | 1.0000 |
ARDS, n | 12 | 13 | 1.0000 |
Heart failure/pulmonary edema, n | 3 | 2 | 0.6539 |
DIC, n | 1 | 2 | 1.0000 |
Surgical debridement, n | 1 | 1 | 1.0000 |
Use of vasopressors, n | 15 | 16 | 1.0000 |
Mechanical ventilation, n | 10 | 10 | 1.0000 |
Table 2 Comparison of secondary outcome measures
Variable | Study group | Control group | P value |
Duration of ICU stay (d) | 7.40 ± 1.35 | 9.19 ± 2.99 | 0.0420 |
Time to target TG (d) | 3.47 ± 0.52 | 7.90 ± 1.14 | < 0.0001 |
Systemic complications, n (%) | 9 (60.00) | 8 (50.00) | 0.7224 |
Local complications, n (%) | 12 (80.00) | 13 (81.25) | 1.0000 |
Table 3 Comparison of physiologic variables
Variable | Study group(n = 15) | Control group(n = 16) |
Body temperature (°C) | 37.5 ± 0.6 | 37.3 ± 0.4 |
Heart rate (beats/min) | 86 ± 14 | 90 ± 19 |
RR interval (beats/min) | 16 ± 4 | 18 ± 5 |
Mean arterial pressure (mmHg) | 70.2 ± 9.3 | 67.9 ± 6.0 |
PaO2/FiO2 | 179.1 ± 41.9 | 167.7 ± 38.9 |
Table 4 Comparison of laboratory variables
Variable | Study group (n = 15) | Control group (n = 16) |
WBC (109/L) | 11.5 ± 2.3 | 13.1 ± 2.9 |
PLT (109/L) | 196.5 ± 40.5 | 199.6 ± 58.7 |
ALB (g/L) | 37.8 ± 4.6a | 38.9 ± 5.7 |
ALT (U/L) | 54.3 ± 20.4 | 59.7 ± 23.1 |
TBIL (mmol/L) | 20.1 ± 3.9 | 25.3 ± 4.2 |
BUN (mmol/L) | 7.8 ± 2.6 | 9.7 ± 2.8 |
Scr (mmol/L) | 149.8 ± 30.2 | 139.3 ± 37.5 |
Ca2+ (mmol/L) | 2.1 ± 0.5 | 2.0 ± 0.3 |
Serum amylase (U/L) | 74.4 ± 28.3 | 82.1 ± 20.7 |
Urine amylase (U/L) | 399.7 ± 59.7 | 387.1 ± 51.4 |
CRP (mg/L) | 20.5 ± 6.4a | 28.5 ± 7.1 |
PCT (ng/mL) | 1.33 ± 0.42a | 1.71 ± 0.61 |
- Citation: Wang HL, Yu KJ. Sequential blood purification therapy for critical patients with hyperlipidemic severe acute pancreatitis. World J Gastroenterol 2015; 21(20): 6304-6309
- URL: https://www.wjgnet.com/1007-9327/full/v21/i20/6304.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i20.6304